The Role of FDG PET in Response Assessment
Twyla Bartel, DO, MBA, FACNM, FSNMMI
Simin Dadparvar, MD, FACNM, FSNMMI
Ashwin Parihar, MBBS, MD
Mallinkrodt Institute of Radiology
18F-FDG PET plays a vital role in the response assessment of several lymphoid and solid malignancies which influences clinical decisions and affects patient outcomes. This webinar will focus on a practical approach to using 18F-FDG PET for assessing response to treatment in different malignancies with emphasis on the clinical relevance of the PET findings. A brief discussion on assessing response to immunotherapy and relevant distinct imaging findings on 18F-FDG PET will also be included.
- Understand 18F-FDG PET based response assessment in lymphomas – how, when, and why?
- Explain 8F-FDG PET based response assessment in solid tumors –PERCIST, and practical application tips
- Discuss basics of 18F-FDG PET based response assessment in immunotherapy – challenges and solutions
CE Credit applications for physicians, pharmacists, physicists and technologists are pending. Check back for updates regarding CE Credit status.